01 1DARMERICA, LLC
02 1HAS Healthcare Advanced Synthesis SA
01 1Anamorelin HCI
02 1Anamorelin Hydrochloride
01 1Switzerland
02 1U.S.A
NDC Package Code : 71052-071
Start Marketing Date : 2024-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67262-0006
Start Marketing Date : 2014-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Anamorelin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anamorelin HCl, including repackagers and relabelers. The FDA regulates Anamorelin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anamorelin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anamorelin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anamorelin HCl supplier is an individual or a company that provides Anamorelin HCl active pharmaceutical ingredient (API) or Anamorelin HCl finished formulations upon request. The Anamorelin HCl suppliers may include Anamorelin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Anamorelin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anamorelin HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anamorelin HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anamorelin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anamorelin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anamorelin HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anamorelin HCl suppliers with NDC on PharmaCompass.
We have 2 companies offering Anamorelin HCl
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
